Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines

Biochemical and Biophysical Research Communications

Volumn 300, Issue 3, 2003, Pages 669-673

  Miyagawa, Yasuhiro ^a   Ohguro, Hiroshi ^a   Odagiri, Hiroki ^a   Maruyama, Ikuyo ^a   Maeda, Tadao ^b   Maeda, Akiko ^b   Sasaki, Mutsuo ^a   Nakazawa, Mitsuru ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer associated retinopathy; Caveolin 1; Cell proliferation; G protein coupled receptor kinase; Paraneoplastic syndrome; Recoverin

Indexed keywords

CAVEOLIN 1; G PROTEIN COUPLED RECEPTOR KINASE; MONOCLONAL ANTIBODY; RECOVERIN;

ARTICLE; CANCER CELL CULTURE; CELL FUNCTION; CELL LYSATE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

EID: 0037449855     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02888-7     Document Type: Article

References (21)

1. Jacobson D.M., Thirkill C.E., Tipping S.J. A clinical triad to diagnose paraneoplastic retinopathy. Ann. Neurol. 28:1990;162-167.
2. Polans A.S., Burton M.D., Harley T.L., Crabb J.W., Palczewski K. Recoverin, but not visinin is an autoantigen in human retina identified with a cancer-associated retinopathy. Invest. Ophthalmol. Vis. Sci. 34:1993;81-90.
3. Kawamura S. Rhodopsin phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin. Nature. 362:1993;855-857.
4. Maeda T., Maeda A., Maruyama I., Ogawa K., Kuroki Y., Sabara H., Sato N., Ohguro H. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest. Ophthalmol. Vis. Sci. 42:2001;705-712.
5. Polans A.S., Witkowska D., Haley T.L., Amundson D., Baizer L., Adamus G. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc. Natl. Acad. Sci. USA. 92:1995;9176-9180.
6. Maeda A., Ohguro H., Maeda T., Wada I., Sato N., Kuroki Y., Nakagawa T. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res. 60:2000;1914-1920.
7. Maeda A., Ohguro H., Nabeta Y., Hirohashi Y., Sahara H., Maeda T., Wada Y., Sato T., Yun C., Nishimura Y., Torigoe T., Kuroki Y., Sato N. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. Eur. J. Immunol. 31:2001;563-572.
8. Pitcher J.A., Freedman N.J., Lefkowitz R.J. G-protein-coupled receptor kinases. Annu. Rev. Biochem. 67:1998;653-692.
9. Carman C.V., Lisanti M.P., Benovic J.L. Regulation of G-protein-coupled receptor kinases by caveolin. J. Biol. Chem. 274:1999;8858-8864.
10. Ohguro H., Chiba S., Igarashi Y., Matsumoto H., Akino T., Palczewski K. β -arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients Proc. Natl. Acad. Sci. USA. 90:1993;3241-3245.
11. Eason M.G., Moreira S.P., Liggett S.B. Four consecutive serines in the third intracellular loop are the sites for. β -adrenergic receptor kinase-mediated phosphorylation and desensitization of the α 2A-adrenergic receptor J. Biol. Chem. 270:1995;4681-4688.
12. Okamoto T., Schlegel A., Scherer P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:1998;5419-5422.
13. Scherer P.E., Okamoto T., Chun M., Nishimoto I., Lodish H.F., Lisanti M.P. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA. 93:1996;131-135.
14. Song K.S., Scherer P.E., Tang Z., Okamoto T., Li S., Chafel M., Chu C., Kohtz D.S., Lisanti M.P. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J. Biol. Chem. 271:1996;15160-15165.
15. Couet J., Sagiacomo M., Lisanti M.P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. J. Biol. Chem. 272:1997;30429-30438.
16. Liu P., Ying Y., Anderson R.G. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc. Natl. Acad. Sci. USA. 94:1997;13666-13670.
17. Wary K.K., Margiotti A., Zurzolo C., Ciancotti F.G. A requirement for caveolin-1 and associated kinase Fyn in integral signaling and anchorage-dependent cell growth. Cell. 94:1998;625-634.
18. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. J. Biol. Chem. 272:1997;6525-6533.
19. Yang G., Truong L.D., Timme T.L., Ren C., Wheeler T.M., Park S.H., Nasu Y., Bangma C.H., Kattan M.W., Scardino P.T., Thompson T.C. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4:1998;1873-1880.
20. Lavie Y., Fiucci G., Liscovitch M. Upregulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273:1998;32380-32383.
21. Yang C.P., Galbiati F., Volonte D., Horwitz S.B., Lisanti M.P. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett. 439:1998;368-372.